| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rhabdomyosarcoma | 18 | 2021 | 358 | 1.800 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 9 | 2025 | 75 | 1.620 |
Why?
|
| Rhabdomyosarcoma, Alveolar | 5 | 2021 | 43 | 1.400 |
Why?
|
| Lupus Nephritis | 8 | 2025 | 324 | 1.400 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 6 | 2021 | 99 | 1.330 |
Why?
|
| Lupus Erythematosus, Systemic | 15 | 2024 | 2160 | 0.990 |
Why?
|
| Protein Phosphatase 2 | 7 | 2024 | 231 | 0.960 |
Why?
|
| Oncogene Proteins, Fusion | 12 | 2014 | 1608 | 0.930 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 3 | 2019 | 336 | 0.740 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 8 | 2012 | 43 | 0.730 |
Why?
|
| Immunohistochemistry | 42 | 2021 | 11062 | 0.690 |
Why?
|
| Membrane Glycoproteins | 14 | 2024 | 3702 | 0.640 |
Why?
|
| Neuroblastoma | 17 | 2016 | 1266 | 0.620 |
Why?
|
| Th17 Cells | 8 | 2024 | 790 | 0.610 |
Why?
|
| Autopsy | 5 | 2004 | 1011 | 0.590 |
Why?
|
| Benzylamines | 1 | 2019 | 251 | 0.580 |
Why?
|
| Hypothermia | 2 | 2012 | 189 | 0.560 |
Why?
|
| Podocytes | 4 | 2025 | 404 | 0.550 |
Why?
|
| Thrombospondin 1 | 9 | 2012 | 257 | 0.520 |
Why?
|
| T-Lymphocytes, Regulatory | 10 | 2024 | 3114 | 0.510 |
Why?
|
| Neuroectodermal Tumors, Primitive | 4 | 2009 | 136 | 0.510 |
Why?
|
| Sarcoma, Synovial | 2 | 2012 | 157 | 0.460 |
Why?
|
| S100 Proteins | 3 | 2014 | 215 | 0.460 |
Why?
|
| Interleukin-2 | 6 | 2024 | 1895 | 0.440 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2018 | 2902 | 0.420 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 3 | 2024 | 283 | 0.390 |
Why?
|
| Tumor Cells, Cultured | 30 | 2016 | 6105 | 0.390 |
Why?
|
| Apoptosis | 22 | 2021 | 9514 | 0.390 |
Why?
|
| Postmortem Changes | 3 | 2001 | 119 | 0.390 |
Why?
|
| Desmoplastic Small Round Cell Tumor | 1 | 2012 | 33 | 0.390 |
Why?
|
| Autoimmunity | 9 | 2024 | 1361 | 0.380 |
Why?
|
| Gene Fusion | 1 | 2014 | 356 | 0.370 |
Why?
|
| Lactoferrin | 2 | 2002 | 100 | 0.370 |
Why?
|
| Complement Activation | 5 | 2022 | 447 | 0.370 |
Why?
|
| Arthritis, Experimental | 2 | 2023 | 293 | 0.360 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2013 | 724 | 0.360 |
Why?
|
| Transcription Factors | 9 | 2018 | 12159 | 0.340 |
Why?
|
| Bone Neoplasms | 14 | 2009 | 2561 | 0.340 |
Why?
|
| Sepsis | 5 | 2002 | 2604 | 0.340 |
Why?
|
| Synovial Fluid | 1 | 2012 | 391 | 0.330 |
Why?
|
| Microscopy, Electron | 26 | 2015 | 2551 | 0.330 |
Why?
|
| Sulfonamides | 2 | 2019 | 1982 | 0.330 |
Why?
|
| Phosphoproteins | 2 | 2018 | 2448 | 0.330 |
Why?
|
| Synovial Membrane | 3 | 2012 | 536 | 0.330 |
Why?
|
| Complement System Proteins | 3 | 2022 | 738 | 0.320 |
Why?
|
| Nanoparticles | 2 | 2019 | 1966 | 0.320 |
Why?
|
| Mice | 68 | 2025 | 81898 | 0.310 |
Why?
|
| RNA-Binding Protein EWS | 7 | 2012 | 211 | 0.300 |
Why?
|
| Membrane Proteins | 12 | 2021 | 7869 | 0.300 |
Why?
|
| T-Lymphocytes | 9 | 2021 | 10263 | 0.290 |
Why?
|
| Apoptosis Regulatory Proteins | 6 | 2012 | 1150 | 0.290 |
Why?
|
| Mice, Inbred MRL lpr | 4 | 2024 | 159 | 0.290 |
Why?
|
| Cause of Death | 6 | 2013 | 3717 | 0.290 |
Why?
|
| Succinate Dehydrogenase | 3 | 2015 | 148 | 0.290 |
Why?
|
| Adrenal Gland Neoplasms | 4 | 2007 | 732 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2012 | 1405 | 0.270 |
Why?
|
| Palatal Neoplasms | 1 | 2006 | 37 | 0.270 |
Why?
|
| Palate, Hard | 1 | 2006 | 59 | 0.270 |
Why?
|
| Methylmalonyl-CoA Mutase | 2 | 2018 | 23 | 0.270 |
Why?
|
| Soft Tissue Neoplasms | 10 | 2005 | 1163 | 0.270 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 7 | 2006 | 104 | 0.260 |
Why?
|
| Humans | 210 | 2024 | 766812 | 0.260 |
Why?
|
| Animals | 84 | 2025 | 168939 | 0.260 |
Why?
|
| DNA, Neoplasm | 8 | 2004 | 1741 | 0.260 |
Why?
|
| bcl-Associated Death Protein | 1 | 2006 | 102 | 0.260 |
Why?
|
| Erythrocytes | 5 | 2020 | 2412 | 0.260 |
Why?
|
| Adolescent | 59 | 2021 | 88902 | 0.260 |
Why?
|
| Fibroblast Growth Factors | 2 | 2024 | 871 | 0.250 |
Why?
|
| Receptors, Tumor Necrosis Factor | 3 | 2004 | 588 | 0.250 |
Why?
|
| Interleukin-17 | 3 | 2024 | 923 | 0.240 |
Why?
|
| Neoplasms, Muscle Tissue | 2 | 2003 | 68 | 0.240 |
Why?
|
| Th1 Cells | 2 | 2021 | 1040 | 0.240 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2007 | 243 | 0.240 |
Why?
|
| Hemorrhage | 2 | 2012 | 3464 | 0.230 |
Why?
|
| Child | 57 | 2021 | 80670 | 0.230 |
Why?
|
| Carrier Proteins | 6 | 2019 | 4926 | 0.230 |
Why?
|
| Carcinoma, Small Cell | 3 | 1997 | 419 | 0.230 |
Why?
|
| Mitochondria | 7 | 2022 | 3678 | 0.230 |
Why?
|
| Abdominal Neoplasms | 3 | 2008 | 286 | 0.220 |
Why?
|
| Erythema | 1 | 2005 | 261 | 0.220 |
Why?
|
| Reperfusion Injury | 3 | 2017 | 1043 | 0.220 |
Why?
|
| Cell Differentiation | 22 | 2024 | 11657 | 0.220 |
Why?
|
| Knee Joint | 2 | 2012 | 1682 | 0.210 |
Why?
|
| Interleukin-23 | 2 | 2023 | 202 | 0.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2006 | 2887 | 0.210 |
Why?
|
| Phosphofructokinases | 1 | 2022 | 6 | 0.210 |
Why?
|
| Achlorhydria | 2 | 1999 | 8 | 0.210 |
Why?
|
| Mice, Knockout | 19 | 2025 | 14473 | 0.210 |
Why?
|
| Lectins | 2 | 2022 | 490 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2003 | 4349 | 0.210 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 5690 | 0.210 |
Why?
|
| Adult | 81 | 2021 | 223305 | 0.210 |
Why?
|
| Lipodystrophy | 1 | 2024 | 145 | 0.210 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2003 | 88 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2014 | 4570 | 0.200 |
Why?
|
| Kidney Neoplasms | 7 | 2013 | 4282 | 0.200 |
Why?
|
| Heart Injuries | 1 | 2004 | 207 | 0.200 |
Why?
|
| Female | 111 | 2025 | 396532 | 0.200 |
Why?
|
| Interferon-gamma | 6 | 2024 | 3157 | 0.200 |
Why?
|
| Mucolipidoses | 2 | 1999 | 82 | 0.200 |
Why?
|
| Forensic Medicine | 1 | 2002 | 68 | 0.190 |
Why?
|
| Muscular Diseases | 2 | 2013 | 551 | 0.190 |
Why?
|
| Neuroectodermal Tumors | 2 | 2001 | 23 | 0.190 |
Why?
|
| Gastrins | 2 | 2008 | 75 | 0.190 |
Why?
|
| MyoD Protein | 2 | 2021 | 143 | 0.190 |
Why?
|
| Collagen | 5 | 2003 | 2635 | 0.190 |
Why?
|
| Skin | 6 | 2019 | 4499 | 0.180 |
Why?
|
| DNA-Binding Proteins | 6 | 2017 | 9613 | 0.180 |
Why?
|
| Calcium Signaling | 2 | 2021 | 736 | 0.180 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2021 | 99 | 0.180 |
Why?
|
| Muramidase | 1 | 2001 | 163 | 0.180 |
Why?
|
| Nose Neoplasms | 2 | 2001 | 250 | 0.180 |
Why?
|
| Parietal Cells, Gastric | 2 | 1999 | 39 | 0.180 |
Why?
|
| Complement Pathway, Alternative | 1 | 2021 | 113 | 0.180 |
Why?
|
| Metalloendopeptidases | 2 | 1999 | 386 | 0.180 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2001 | 141 | 0.180 |
Why?
|
| Male | 99 | 2021 | 364154 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2015 | 705 | 0.180 |
Why?
|
| Calcium | 4 | 2024 | 5783 | 0.180 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2000 | 102 | 0.180 |
Why?
|
| Nitric Oxide | 8 | 2020 | 2140 | 0.180 |
Why?
|
| Inclusion Bodies | 3 | 2004 | 277 | 0.180 |
Why?
|
| Genes, myc | 3 | 2008 | 391 | 0.170 |
Why?
|
| Death, Sudden | 1 | 2002 | 301 | 0.170 |
Why?
|
| CD4-Positive T-Lymphocytes | 6 | 2024 | 4410 | 0.170 |
Why?
|
| NAD | 1 | 2024 | 617 | 0.170 |
Why?
|
| Skin Neoplasms | 3 | 2014 | 5860 | 0.170 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 4 | 2007 | 195 | 0.170 |
Why?
|
| Lung | 5 | 2021 | 10068 | 0.170 |
Why?
|
| Calcitonin | 2 | 2001 | 327 | 0.170 |
Why?
|
| Gastritis, Atrophic | 1 | 1999 | 31 | 0.170 |
Why?
|
| Pulmonary Alveoli | 2 | 2002 | 665 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 22 | 2025 | 22351 | 0.170 |
Why?
|
| Doxorubicin | 6 | 2019 | 2229 | 0.170 |
Why?
|
| Dendritic Cells | 5 | 2008 | 2747 | 0.170 |
Why?
|
| Cell Membrane | 3 | 2024 | 3642 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2008 | 4523 | 0.160 |
Why?
|
| Forensic Pathology | 2 | 2012 | 23 | 0.160 |
Why?
|
| RNA, Neoplasm | 6 | 2006 | 748 | 0.160 |
Why?
|
| Esthesioneuroblastoma, Olfactory | 1 | 1999 | 58 | 0.160 |
Why?
|
| Muscle Neoplasms | 1 | 2000 | 130 | 0.160 |
Why?
|
| Child, Preschool | 35 | 2018 | 42577 | 0.160 |
Why?
|
| Kidney Tubules | 1 | 2021 | 454 | 0.160 |
Why?
|
| Sarcoma | 9 | 2016 | 1802 | 0.160 |
Why?
|
| Hemoglobins | 1 | 2005 | 1531 | 0.160 |
Why?
|
| Antibiotics, Antineoplastic | 3 | 2019 | 678 | 0.160 |
Why?
|
| Drowning | 1 | 1999 | 27 | 0.160 |
Why?
|
| Wounds and Injuries | 3 | 2020 | 2513 | 0.160 |
Why?
|
| Mesangial Cells | 1 | 2018 | 23 | 0.160 |
Why?
|
| Pleural Neoplasms | 3 | 2015 | 584 | 0.160 |
Why?
|
| Autophagy | 4 | 2012 | 1345 | 0.150 |
Why?
|
| Nanoconjugates | 1 | 2018 | 22 | 0.150 |
Why?
|
| Lymphopoiesis | 1 | 2019 | 133 | 0.150 |
Why?
|
| Tissue Array Analysis | 2 | 2018 | 545 | 0.150 |
Why?
|
| Neoplasms, Second Primary | 4 | 2009 | 1062 | 0.150 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2021 | 235 | 0.150 |
Why?
|
| Desmin | 3 | 2007 | 99 | 0.150 |
Why?
|
| Response Elements | 2 | 2018 | 308 | 0.150 |
Why?
|
| Signal Transduction | 15 | 2021 | 23618 | 0.150 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 1998 | 100 | 0.150 |
Why?
|
| Bronchi | 1 | 2002 | 847 | 0.150 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2004 | 807 | 0.150 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2024 | 1814 | 0.150 |
Why?
|
| Infant | 17 | 2021 | 36459 | 0.150 |
Why?
|
| Kidney | 4 | 2022 | 7073 | 0.150 |
Why?
|
| E-Selectin | 1 | 2000 | 576 | 0.140 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2019 | 565 | 0.140 |
Why?
|
| Middle Aged | 47 | 2021 | 223267 | 0.140 |
Why?
|
| Nasal Cavity | 1 | 1999 | 310 | 0.140 |
Why?
|
| Virus Diseases | 2 | 2022 | 721 | 0.140 |
Why?
|
| Leiomyomatosis | 2 | 2010 | 69 | 0.140 |
Why?
|
| Autoimmune Diseases | 4 | 2019 | 2255 | 0.140 |
Why?
|
| Jurkat Cells | 4 | 2024 | 740 | 0.140 |
Why?
|
| Phosphopyruvate Hydratase | 6 | 1997 | 128 | 0.140 |
Why?
|
| Immunoenzyme Techniques | 9 | 2001 | 1697 | 0.140 |
Why?
|
| B-Lymphocytes | 2 | 2021 | 4787 | 0.140 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2001 | 1131 | 0.140 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2018 | 327 | 0.140 |
Why?
|
| Azacitidine | 1 | 2018 | 337 | 0.130 |
Why?
|
| Mucin-1 | 1 | 2021 | 536 | 0.130 |
Why?
|
| Mice, Nude | 12 | 2015 | 3618 | 0.130 |
Why?
|
| Protein Precursors | 1 | 2001 | 1134 | 0.130 |
Why?
|
| Neoplasm Proteins | 7 | 2006 | 3600 | 0.130 |
Why?
|
| Lymphocyte Activation | 4 | 2021 | 5502 | 0.130 |
Why?
|
| Thyroid Hormones | 1 | 2019 | 408 | 0.130 |
Why?
|
| Accidental Falls | 1 | 2004 | 1077 | 0.130 |
Why?
|
| Lung Injury | 1 | 2021 | 432 | 0.130 |
Why?
|
| Integrins | 1 | 2001 | 839 | 0.130 |
Why?
|
| Caspases | 4 | 2007 | 881 | 0.130 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 484 | 0.130 |
Why?
|
| Autoantigens | 1 | 2020 | 890 | 0.130 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2003 | 2426 | 0.130 |
Why?
|
| Osteogenesis | 1 | 2023 | 1282 | 0.130 |
Why?
|
| Macrostomia | 1 | 2015 | 6 | 0.130 |
Why?
|
| Kidney Glomerulus | 1 | 2018 | 571 | 0.130 |
Why?
|
| Tretinoin | 3 | 2016 | 524 | 0.130 |
Why?
|
| Disease Models, Animal | 9 | 2020 | 18329 | 0.130 |
Why?
|
| Aged, 80 and over | 14 | 2021 | 59548 | 0.130 |
Why?
|
| Hypertelorism | 1 | 2015 | 29 | 0.130 |
Why?
|
| Carcinoma, Renal Cell | 4 | 2013 | 3186 | 0.130 |
Why?
|
| Fas Ligand Protein | 4 | 2001 | 216 | 0.130 |
Why?
|
| Caspase 8 | 3 | 2007 | 198 | 0.130 |
Why?
|
| Emergency Treatment | 2 | 2013 | 495 | 0.120 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2001 | 621 | 0.120 |
Why?
|
| DNA Methylation | 3 | 2019 | 4427 | 0.120 |
Why?
|
| Hypertrichosis | 1 | 2015 | 31 | 0.120 |
Why?
|
| Hirsutism | 1 | 2015 | 66 | 0.120 |
Why?
|
| Flow Cytometry | 9 | 2020 | 5890 | 0.120 |
Why?
|
| Immunoglobulin G | 3 | 2024 | 4559 | 0.120 |
Why?
|
| Cushing Syndrome | 3 | 2005 | 241 | 0.120 |
Why?
|
| Lysosomes | 2 | 2002 | 937 | 0.120 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2015 | 47 | 0.120 |
Why?
|
| Chondroma | 1 | 2015 | 53 | 0.120 |
Why?
|
| Ceramides | 2 | 2016 | 202 | 0.120 |
Why?
|
| Aged | 31 | 2021 | 171344 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2013 | 8623 | 0.120 |
Why?
|
| Skin Abnormalities | 1 | 2015 | 60 | 0.120 |
Why?
|
| Staining and Labeling | 2 | 2018 | 1075 | 0.120 |
Why?
|
| Complement C3 | 1 | 2016 | 434 | 0.120 |
Why?
|
| Muscle, Skeletal | 4 | 2011 | 4968 | 0.120 |
Why?
|
| Case-Control Studies | 8 | 2020 | 22248 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2015 | 2801 | 0.120 |
Why?
|
| Osteosarcoma | 3 | 2009 | 908 | 0.120 |
Why?
|
| Antibodies | 4 | 2009 | 2421 | 0.120 |
Why?
|
| Rhabdoid Tumor | 2 | 2012 | 211 | 0.120 |
Why?
|
| Myogenin | 2 | 2007 | 54 | 0.120 |
Why?
|
| Neoplasm Transplantation | 9 | 2015 | 2012 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2016 | 2571 | 0.110 |
Why?
|
| Mesothelioma | 3 | 2015 | 774 | 0.110 |
Why?
|
| Ischemia | 3 | 2007 | 1905 | 0.110 |
Why?
|
| Blotting, Western | 6 | 2016 | 5022 | 0.110 |
Why?
|
| Translocation, Genetic | 4 | 2008 | 1392 | 0.110 |
Why?
|
| Mutation, Missense | 2 | 2021 | 2591 | 0.110 |
Why?
|
| Cell Nucleus | 3 | 2018 | 2875 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 1168 | 0.110 |
Why?
|
| Xeroderma Pigmentosum | 1 | 2013 | 31 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1999 | 996 | 0.110 |
Why?
|
| Genetic Vectors | 3 | 2008 | 3401 | 0.110 |
Why?
|
| Young Adult | 12 | 2021 | 59939 | 0.110 |
Why?
|
| Eyelid Diseases | 1 | 2015 | 155 | 0.110 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2006 | 263 | 0.110 |
Why?
|
| Phenotype | 10 | 2018 | 16722 | 0.110 |
Why?
|
| Interleukin-6 | 2 | 2001 | 3226 | 0.100 |
Why?
|
| Adrenal Cortex Neoplasms | 2 | 2005 | 161 | 0.100 |
Why?
|
| Mice, Transgenic | 7 | 2024 | 9546 | 0.100 |
Why?
|
| Eye Abnormalities | 1 | 2015 | 243 | 0.100 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 2 | 2003 | 46 | 0.100 |
Why?
|
| Microsporidia | 1 | 2012 | 6 | 0.100 |
Why?
|
| Adenoviridae | 2 | 2007 | 1093 | 0.100 |
Why?
|
| Demyelinating Diseases | 2 | 2006 | 354 | 0.100 |
Why?
|
| Drug Delivery Systems | 2 | 2019 | 2210 | 0.100 |
Why?
|
| Stomach Neoplasms | 2 | 2015 | 1480 | 0.100 |
Why?
|
| In Situ Hybridization, Fluorescence | 7 | 2010 | 2510 | 0.100 |
Why?
|
| Microsporidiosis | 1 | 2012 | 23 | 0.100 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2019 | 1852 | 0.100 |
Why?
|
| Paraffin Embedding | 3 | 2000 | 303 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2012 | 76 | 0.100 |
Why?
|
| Traumatology | 1 | 2013 | 101 | 0.100 |
Why?
|
| Adaptor Protein Complex 3 | 1 | 2012 | 17 | 0.100 |
Why?
|
| Nerve Sheath Neoplasms | 2 | 2012 | 169 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 3 | 2024 | 1627 | 0.100 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2016 | 527 | 0.100 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2012 | 20 | 0.100 |
Why?
|
| Endoplasmic Reticulum | 4 | 2021 | 1132 | 0.100 |
Why?
|
| Antineoplastic Agents | 7 | 2018 | 13644 | 0.100 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2013 | 325 | 0.100 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1999 | 949 | 0.100 |
Why?
|
| Phosphorylcholine | 1 | 2012 | 152 | 0.100 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2015 | 456 | 0.100 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2013 | 289 | 0.100 |
Why?
|
| Calcium Phosphates | 1 | 2013 | 172 | 0.100 |
Why?
|
| Neurofibroma, Plexiform | 1 | 2012 | 66 | 0.100 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2012 | 201 | 0.100 |
Why?
|
| Secretory Vesicles | 1 | 2012 | 127 | 0.090 |
Why?
|
| Cachexia | 1 | 2013 | 202 | 0.090 |
Why?
|
| Multiple Endocrine Neoplasia Type 1 | 2 | 2004 | 43 | 0.090 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 2 | 2001 | 46 | 0.090 |
Why?
|
| Fatal Outcome | 6 | 2021 | 1838 | 0.090 |
Why?
|
| Nevus, Pigmented | 1 | 1993 | 222 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 7 | 2016 | 6066 | 0.090 |
Why?
|
| N-Acetylneuraminic Acid | 2 | 2009 | 174 | 0.090 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2013 | 386 | 0.090 |
Why?
|
| Neoplasms, Nerve Tissue | 1 | 1991 | 20 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2018 | 1407 | 0.090 |
Why?
|
| Intestine, Small | 1 | 2017 | 1217 | 0.090 |
Why?
|
| Retinoblastoma | 2 | 2001 | 321 | 0.090 |
Why?
|
| RNA, Small Interfering | 4 | 2013 | 3427 | 0.090 |
Why?
|
| Leiomyosarcoma | 1 | 2015 | 426 | 0.090 |
Why?
|
| Lymphocytes | 2 | 2017 | 2606 | 0.090 |
Why?
|
| Phagocytes | 1 | 2012 | 292 | 0.090 |
Why?
|
| Pituitary Gland | 3 | 2006 | 635 | 0.090 |
Why?
|
| Gene Rearrangement | 3 | 2012 | 1141 | 0.090 |
Why?
|
| Cell Division | 12 | 2003 | 4473 | 0.090 |
Why?
|
| Formaldehyde | 3 | 2000 | 360 | 0.090 |
Why?
|
| Cells, Cultured | 13 | 2021 | 18986 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 2823 | 0.090 |
Why?
|
| Dilatation, Pathologic | 1 | 2012 | 527 | 0.090 |
Why?
|
| Radiation Tolerance | 2 | 2009 | 476 | 0.090 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 1993 | 335 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 4 | 2001 | 1612 | 0.090 |
Why?
|
| Lymphoma, B-Cell | 4 | 2006 | 945 | 0.080 |
Why?
|
| Ectoderm | 2 | 2000 | 138 | 0.080 |
Why?
|
| Candidiasis | 1 | 2012 | 372 | 0.080 |
Why?
|
| Sialic Acid Storage Disease | 1 | 2009 | 2 | 0.080 |
Why?
|
| Transplantation, Heterologous | 5 | 2012 | 2391 | 0.080 |
Why?
|
| PPAR alpha | 1 | 2011 | 177 | 0.080 |
Why?
|
| Fumarate Hydratase | 1 | 2010 | 55 | 0.080 |
Why?
|
| Thymus Neoplasms | 1 | 2012 | 272 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2022 | 2505 | 0.080 |
Why?
|
| Pituitary Neoplasms | 3 | 2004 | 1324 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 5 | 2013 | 685 | 0.080 |
Why?
|
| Coagulation Protein Disorders | 1 | 2008 | 6 | 0.080 |
Why?
|
| Leptin | 3 | 2011 | 1596 | 0.080 |
Why?
|
| Prognosis | 9 | 2021 | 29959 | 0.080 |
Why?
|
| Adrenal Cortex Diseases | 2 | 2004 | 13 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2001 | 3853 | 0.080 |
Why?
|
| Cell Line, Tumor | 12 | 2016 | 17089 | 0.080 |
Why?
|
| Pseudoxanthoma Elasticum | 1 | 2008 | 14 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 3803 | 0.080 |
Why?
|
| Loss of Heterozygosity | 3 | 2013 | 663 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2003 | 3788 | 0.080 |
Why?
|
| Models, Biological | 4 | 2010 | 9464 | 0.080 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2016 | 1503 | 0.080 |
Why?
|
| Receptor, IGF Type 1 | 3 | 2012 | 385 | 0.080 |
Why?
|
| Nerve Degeneration | 1 | 2013 | 748 | 0.080 |
Why?
|
| Cell Line | 12 | 2021 | 15564 | 0.080 |
Why?
|
| Radiation Protection | 1 | 2012 | 425 | 0.080 |
Why?
|
| Organic Anion Transporters | 1 | 2009 | 101 | 0.080 |
Why?
|
| Caloric Restriction | 1 | 2011 | 303 | 0.080 |
Why?
|
| rho-Associated Kinases | 2 | 2021 | 290 | 0.080 |
Why?
|
| Endocytosis | 1 | 2013 | 951 | 0.080 |
Why?
|
| Tissue Survival | 1 | 2008 | 120 | 0.080 |
Why?
|
| Neurilemmoma | 1 | 1993 | 522 | 0.080 |
Why?
|
| Receptors, Interleukin | 2 | 2021 | 243 | 0.080 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2008 | 88 | 0.080 |
Why?
|
| Gastrinoma | 1 | 2008 | 20 | 0.080 |
Why?
|
| Supratentorial Neoplasms | 1 | 2009 | 156 | 0.080 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2012 | 488 | 0.070 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 3 | 2004 | 58 | 0.070 |
Why?
|
| Pulmonary Fibrosis | 1 | 2012 | 505 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 1424 | 0.070 |
Why?
|
| Gene Expression Regulation | 5 | 2021 | 11924 | 0.070 |
Why?
|
| Chromaffin Cells | 1 | 2007 | 10 | 0.070 |
Why?
|
| Nelfinavir | 1 | 2007 | 68 | 0.070 |
Why?
|
| Immunotherapy | 3 | 2022 | 4747 | 0.070 |
Why?
|
| Kidney Diseases | 3 | 2018 | 2101 | 0.070 |
Why?
|
| Spectral Karyotyping | 2 | 2005 | 12 | 0.070 |
Why?
|
| Organ Specificity | 1 | 2012 | 1968 | 0.070 |
Why?
|
| Genes | 1 | 1991 | 1824 | 0.070 |
Why?
|
| Adenoviridae Infections | 1 | 2008 | 97 | 0.070 |
Why?
|
| Neoplasms | 8 | 2018 | 22350 | 0.070 |
Why?
|
| Insulinoma | 1 | 2008 | 121 | 0.070 |
Why?
|
| Thymus Gland | 3 | 2019 | 1266 | 0.070 |
Why?
|
| Phospholipase C gamma | 2 | 2024 | 130 | 0.070 |
Why?
|
| Niacinamide | 2 | 2024 | 419 | 0.070 |
Why?
|
| Mutation | 6 | 2021 | 30214 | 0.070 |
Why?
|
| Tumor Virus Infections | 2 | 2002 | 438 | 0.070 |
Why?
|
| Polyethylene Glycols | 1 | 2013 | 1189 | 0.070 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 1992 | 497 | 0.070 |
Why?
|
| Neurofibromatosis 1 | 1 | 2012 | 561 | 0.070 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2013 | 616 | 0.070 |
Why?
|
| Blotting, Southern | 2 | 1999 | 774 | 0.070 |
Why?
|
| Paraganglioma | 1 | 2008 | 143 | 0.070 |
Why?
|
| Liver | 5 | 2018 | 7571 | 0.070 |
Why?
|
| RNA, Messenger | 11 | 2006 | 12795 | 0.070 |
Why?
|
| Arabinofuranosyluracil | 2 | 1997 | 10 | 0.070 |
Why?
|
| Immunocompromised Host | 1 | 2012 | 865 | 0.070 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2006 | 85 | 0.070 |
Why?
|
| Anodontia | 1 | 2006 | 51 | 0.070 |
Why?
|
| DNA Primers | 3 | 2013 | 2826 | 0.070 |
Why?
|
| Lung Neoplasms | 7 | 2015 | 13489 | 0.070 |
Why?
|
| Phosphatidylethanolamines | 1 | 2007 | 130 | 0.070 |
Why?
|
| Annexin A5 | 1 | 2006 | 102 | 0.070 |
Why?
|
| Muscle Relaxation | 1 | 2006 | 138 | 0.070 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2006 | 27 | 0.070 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1987 | 205 | 0.070 |
Why?
|
| Paired Box Transcription Factors | 1 | 2007 | 205 | 0.070 |
Why?
|
| Injury Severity Score | 2 | 2014 | 1049 | 0.070 |
Why?
|
| Spinal Nerve Roots | 1 | 2006 | 122 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 1996 | 2952 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 6 | 2012 | 9244 | 0.070 |
Why?
|
| Stomach | 1 | 1991 | 701 | 0.070 |
Why?
|
| Symporters | 1 | 2009 | 363 | 0.070 |
Why?
|
| Vitamin K | 1 | 2008 | 314 | 0.070 |
Why?
|
| Mice, SCID | 5 | 2015 | 2626 | 0.070 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2007 | 204 | 0.070 |
Why?
|
| Adenoviruses, Human | 1 | 2008 | 257 | 0.060 |
Why?
|
| Kidney Transplantation | 2 | 2020 | 4278 | 0.060 |
Why?
|
| Neoplasm Metastasis | 6 | 2008 | 4892 | 0.060 |
Why?
|
| Peptide Fragments | 2 | 2014 | 5143 | 0.060 |
Why?
|
| Rigor Mortis | 1 | 2005 | 1 | 0.060 |
Why?
|
| Adrenal Glands | 5 | 2005 | 556 | 0.060 |
Why?
|
| Prospective Studies | 8 | 2020 | 54872 | 0.060 |
Why?
|
| Seasons | 1 | 2012 | 1519 | 0.060 |
Why?
|
| Wilms Tumor | 2 | 2006 | 378 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 1999 | 2355 | 0.060 |
Why?
|
| alpha-Galactosidase | 1 | 2005 | 58 | 0.060 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 11218 | 0.060 |
Why?
|
| Isoenzymes | 5 | 2003 | 1688 | 0.060 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2011 | 856 | 0.060 |
Why?
|
| Autonomic Nervous System | 1 | 1991 | 707 | 0.060 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2006 | 154 | 0.060 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2006 | 108 | 0.060 |
Why?
|
| Antioxidants | 1 | 2013 | 1671 | 0.060 |
Why?
|
| Cytoplasm | 4 | 1998 | 1505 | 0.060 |
Why?
|
| Bacterial Adhesion | 1 | 2006 | 306 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2012 | 2456 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2001 | 3587 | 0.060 |
Why?
|
| Amyloidosis | 1 | 2013 | 877 | 0.060 |
Why?
|
| Neural Crest | 1 | 1987 | 277 | 0.060 |
Why?
|
| Models, Molecular | 1 | 2015 | 5388 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2001 | 2846 | 0.060 |
Why?
|
| HIV Protease Inhibitors | 1 | 2007 | 430 | 0.060 |
Why?
|
| Fabry Disease | 1 | 2005 | 89 | 0.060 |
Why?
|
| Sirtuins | 1 | 2008 | 322 | 0.060 |
Why?
|
| Pheochromocytoma | 1 | 2007 | 327 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 1993 | 1996 | 0.060 |
Why?
|
| Neutrophils | 3 | 2012 | 3782 | 0.060 |
Why?
|
| Multiple Endocrine Neoplasia | 1 | 2004 | 25 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2009 | 1362 | 0.060 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2007 | 488 | 0.060 |
Why?
|
| Caspase 9 | 2 | 2003 | 184 | 0.060 |
Why?
|
| Germ-Line Mutation | 1 | 2013 | 1886 | 0.060 |
Why?
|
| Whole-Body Irradiation | 4 | 2012 | 438 | 0.060 |
Why?
|
| Melanoma | 2 | 2022 | 5702 | 0.060 |
Why?
|
| NF-kappa B | 3 | 2021 | 2493 | 0.060 |
Why?
|
| Roseolovirus Infections | 1 | 2004 | 50 | 0.060 |
Why?
|
| Dimethyl Sulfoxide | 2 | 2019 | 250 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2015 | 2979 | 0.060 |
Why?
|
| Pyridinium Compounds | 1 | 2024 | 80 | 0.060 |
Why?
|
| Phosphorylation | 5 | 2020 | 8310 | 0.060 |
Why?
|
| Drug Discovery | 1 | 2012 | 1065 | 0.060 |
Why?
|
| Eye Neoplasms | 1 | 1986 | 305 | 0.060 |
Why?
|
| Oxyphil Cells | 1 | 2004 | 56 | 0.060 |
Why?
|
| Adrenocortical Adenoma | 1 | 2004 | 46 | 0.060 |
Why?
|
| Immunosuppressive Agents | 3 | 2018 | 4215 | 0.060 |
Why?
|
| Fibroblasts | 3 | 2003 | 4166 | 0.060 |
Why?
|
| Antigens, Neoplasm | 1 | 2012 | 1998 | 0.060 |
Why?
|
| DNA, Mitochondrial | 2 | 2008 | 872 | 0.060 |
Why?
|
| Hyperplasia | 3 | 2004 | 1150 | 0.060 |
Why?
|
| Transduction, Genetic | 1 | 2007 | 899 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2004 | 482 | 0.060 |
Why?
|
| Cell Line, Transformed | 3 | 2018 | 861 | 0.060 |
Why?
|
| Fibrous Dysplasia, Polyostotic | 1 | 2004 | 39 | 0.060 |
Why?
|
| DNA Repair | 1 | 2013 | 2050 | 0.060 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2003 | 107 | 0.060 |
Why?
|
| Lymphadenitis | 1 | 2004 | 99 | 0.060 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 1600 | 0.050 |
Why?
|
| Lymph Nodes | 4 | 2004 | 3468 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2009 | 1105 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 1987 | 661 | 0.050 |
Why?
|
| Sternum | 1 | 2004 | 177 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 9 | 2014 | 11876 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 2028 | 0.050 |
Why?
|
| Endocardium | 1 | 2004 | 249 | 0.050 |
Why?
|
| Vasculitis, Leukocytoclastic, Cutaneous | 2 | 1995 | 42 | 0.050 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2019 | 820 | 0.050 |
Why?
|
| Asthma | 1 | 2002 | 6266 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2006 | 1989 | 0.050 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 2004 | 126 | 0.050 |
Why?
|
| Endothelial Cells | 2 | 2013 | 3582 | 0.050 |
Why?
|
| Gene Amplification | 2 | 1999 | 1088 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 2025 | 512 | 0.050 |
Why?
|
| Myelin Proteins | 1 | 2003 | 212 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2008 | 3738 | 0.050 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2012 | 940 | 0.050 |
Why?
|
| Up-Regulation | 6 | 2012 | 4143 | 0.050 |
Why?
|
| Liposomes | 1 | 2007 | 787 | 0.050 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2007 | 306 | 0.050 |
Why?
|
| Periodicity | 1 | 2004 | 347 | 0.050 |
Why?
|
| Drug Resistance | 3 | 1994 | 1592 | 0.050 |
Why?
|
| Lymphoma | 5 | 2001 | 1899 | 0.050 |
Why?
|
| Choristoma | 1 | 2004 | 205 | 0.050 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2003 | 122 | 0.050 |
Why?
|
| Cytodiagnosis | 1 | 2006 | 450 | 0.050 |
Why?
|
| Mice, Mutant Strains | 3 | 2021 | 1751 | 0.050 |
Why?
|
| Trifluoroacetic Acid | 1 | 2002 | 5 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2009 | 1802 | 0.050 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2003 | 183 | 0.050 |
Why?
|
| Herpesvirus 4, Human | 2 | 1999 | 1080 | 0.050 |
Why?
|
| Gene Expression | 6 | 2011 | 7585 | 0.050 |
Why?
|
| Skin Transplantation | 1 | 2008 | 1097 | 0.050 |
Why?
|
| Simian virus 40 | 1 | 2002 | 291 | 0.050 |
Why?
|
| Leukocytes | 2 | 2001 | 2034 | 0.050 |
Why?
|
| Pelvic Neoplasms | 2 | 1999 | 249 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2012 | 2703 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 2008 | 1776 | 0.050 |
Why?
|
| Exocrine Glands | 1 | 2002 | 46 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2022 | 4652 | 0.050 |
Why?
|
| Recombinant Proteins | 5 | 2005 | 6507 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 14653 | 0.050 |
Why?
|
| Germany | 1 | 2004 | 882 | 0.050 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2003 | 172 | 0.050 |
Why?
|
| Malacoplakia | 1 | 2001 | 15 | 0.050 |
Why?
|
| BK Virus | 1 | 2002 | 120 | 0.050 |
Why?
|
| Lymphatic Diseases | 1 | 1983 | 318 | 0.050 |
Why?
|
| Blotting, Northern | 4 | 1998 | 1550 | 0.050 |
Why?
|
| Cytokines | 4 | 2023 | 7438 | 0.050 |
Why?
|
| Base Sequence | 7 | 2015 | 12415 | 0.050 |
Why?
|
| Molecular Sequence Data | 9 | 2015 | 17609 | 0.050 |
Why?
|
| Ganglioneuroblastoma | 1 | 2001 | 10 | 0.050 |
Why?
|
| Multiple Trauma | 1 | 2004 | 369 | 0.050 |
Why?
|
| Clone Cells | 2 | 2003 | 1670 | 0.050 |
Why?
|
| Cytochrome c Group | 1 | 2001 | 123 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2013 | 1936 | 0.050 |
Why?
|
| Coatomer Protein | 1 | 2021 | 18 | 0.050 |
Why?
|
| Neuroendocrine Tumors | 1 | 2008 | 659 | 0.050 |
Why?
|
| Autoantibodies | 3 | 2020 | 2115 | 0.050 |
Why?
|
| Hindlimb | 3 | 2008 | 513 | 0.050 |
Why?
|
| Macrophages | 3 | 2020 | 5784 | 0.050 |
Why?
|
| Survival Analysis | 6 | 2005 | 10101 | 0.050 |
Why?
|
| Vulvar Diseases | 1 | 2001 | 64 | 0.050 |
Why?
|
| Discriminant Analysis | 1 | 2001 | 222 | 0.050 |
Why?
|
| Thalidomide | 1 | 2006 | 886 | 0.050 |
Why?
|
| Adenoma | 2 | 2004 | 2155 | 0.050 |
Why?
|
| Complement Inactivating Agents | 1 | 2021 | 53 | 0.050 |
Why?
|
| Gastroscopy | 2 | 1999 | 213 | 0.050 |
Why?
|
| Arginase | 1 | 2021 | 81 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2003 | 663 | 0.050 |
Why?
|
| Treatment Outcome | 8 | 2018 | 65286 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2001 | 187 | 0.050 |
Why?
|
| Linear Models | 2 | 2001 | 5873 | 0.050 |
Why?
|
| Fucose | 1 | 2021 | 115 | 0.050 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2001 | 186 | 0.050 |
Why?
|
| Cycloheximide | 1 | 2001 | 340 | 0.040 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2001 | 60 | 0.040 |
Why?
|
| Urinary Bladder Diseases | 1 | 2001 | 166 | 0.040 |
Why?
|
| Lung Diseases, Fungal | 1 | 2001 | 123 | 0.040 |
Why?
|
| Integrin alpha4beta1 | 1 | 2001 | 119 | 0.040 |
Why?
|
| Neoplasms, Experimental | 2 | 2015 | 1228 | 0.040 |
Why?
|
| Diagnosis, Differential | 7 | 2012 | 12985 | 0.040 |
Why?
|
| Cyclic AMP | 2 | 1995 | 1472 | 0.040 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2001 | 84 | 0.040 |
Why?
|
| Vaginal Diseases | 1 | 2001 | 103 | 0.040 |
Why?
|
| Polyomavirus Infections | 1 | 2002 | 193 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2003 | 616 | 0.040 |
Why?
|
| Abdominal Muscles | 1 | 2001 | 172 | 0.040 |
Why?
|
| Phagocytosis | 2 | 2001 | 1526 | 0.040 |
Why?
|
| Lovastatin | 1 | 2000 | 114 | 0.040 |
Why?
|
| U937 Cells | 2 | 2012 | 260 | 0.040 |
Why?
|
| Hypogonadism | 1 | 2006 | 802 | 0.040 |
Why?
|
| Caffeic Acids | 1 | 2000 | 9 | 0.040 |
Why?
|
| Cell Proliferation | 5 | 2022 | 10451 | 0.040 |
Why?
|
| Enterochromaffin-like Cells | 1 | 1999 | 4 | 0.040 |
Why?
|
| Myocardium | 2 | 2011 | 4765 | 0.040 |
Why?
|
| Keratins | 3 | 1997 | 499 | 0.040 |
Why?
|
| Phenylethyl Alcohol | 1 | 2000 | 13 | 0.040 |
Why?
|
| Aging | 2 | 2011 | 8728 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2006 | 980 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2007 | 1020 | 0.040 |
Why?
|
| Genes, p53 | 2 | 1993 | 711 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 1987 | 2093 | 0.040 |
Why?
|
| Ubiquitin-Activating Enzymes | 2 | 2012 | 85 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2006 | 1494 | 0.040 |
Why?
|
| Microscopy | 1 | 2005 | 902 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2022 | 794 | 0.040 |
Why?
|
| Hymecromone | 1 | 2019 | 9 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2007 | 1610 | 0.040 |
Why?
|
| Gastric Fundus | 1 | 1999 | 37 | 0.040 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2001 | 199 | 0.040 |
Why?
|
| Necrosis | 4 | 2008 | 1614 | 0.040 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2020 | 105 | 0.040 |
Why?
|
| Lipids | 1 | 2011 | 3322 | 0.040 |
Why?
|
| Ploidies | 2 | 2008 | 287 | 0.040 |
Why?
|
| Galactose | 1 | 2021 | 299 | 0.040 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2021 | 234 | 0.040 |
Why?
|
| Pericardium | 1 | 2004 | 681 | 0.040 |
Why?
|
| Cancer Vaccines | 2 | 2011 | 1042 | 0.040 |
Why?
|
| Cell Survival | 5 | 2008 | 5749 | 0.040 |
Why?
|
| Leukopoiesis | 1 | 1999 | 54 | 0.040 |
Why?
|
| Calcimycin | 1 | 1999 | 214 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 1987 | 1730 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 4 | 2018 | 6225 | 0.040 |
Why?
|
| Ionophores | 1 | 1999 | 108 | 0.040 |
Why?
|
| Time Factors | 7 | 2007 | 40149 | 0.040 |
Why?
|
| Bucladesine | 3 | 1992 | 118 | 0.040 |
Why?
|
| G1 Phase | 1 | 2000 | 403 | 0.040 |
Why?
|
| Epithelium | 2 | 2002 | 1606 | 0.040 |
Why?
|
| AIDS Dementia Complex | 1 | 2000 | 154 | 0.040 |
Why?
|
| Aspergillosis | 1 | 2001 | 242 | 0.040 |
Why?
|
| Tissue Fixation | 1 | 2000 | 245 | 0.040 |
Why?
|
| Disintegrins | 1 | 2019 | 27 | 0.040 |
Why?
|
| Naphthoquinones | 1 | 2019 | 60 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2013 | 751 | 0.040 |
Why?
|
| Receptors, Peptide | 1 | 2021 | 280 | 0.040 |
Why?
|
| Artificial Gene Fusion | 1 | 1999 | 56 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 406 | 0.040 |
Why?
|
| I-kappa B Proteins | 1 | 2000 | 210 | 0.040 |
Why?
|
| Pyrroles | 2 | 2012 | 1121 | 0.040 |
Why?
|
| Phenanthrolines | 1 | 1998 | 48 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2012 | 9528 | 0.040 |
Why?
|
| Back | 1 | 1999 | 64 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2016 | 2060 | 0.040 |
Why?
|
| Mice, Inbred NOD | 2 | 2016 | 1836 | 0.040 |
Why?
|
| Phenylbutyrates | 1 | 1999 | 72 | 0.040 |
Why?
|
| Morbidity | 1 | 2004 | 1754 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2020 | 492 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2002 | 642 | 0.040 |
Why?
|
| Survival Rate | 5 | 2008 | 12826 | 0.040 |
Why?
|
| Retinal Neoplasms | 1 | 2001 | 151 | 0.040 |
Why?
|
| Foot Deformities, Congenital | 1 | 1999 | 59 | 0.040 |
Why?
|
| Body Weight | 3 | 2011 | 4626 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 1998 | 71 | 0.040 |
Why?
|
| Neck | 1 | 2003 | 736 | 0.040 |
Why?
|
| Isoflurane | 1 | 2002 | 383 | 0.040 |
Why?
|
| Goblet Cells | 1 | 2002 | 300 | 0.040 |
Why?
|
| Indicators and Reagents | 1 | 2019 | 456 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 2 | 2008 | 5444 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2001 | 462 | 0.040 |
Why?
|
| Combined Modality Therapy | 8 | 2016 | 8540 | 0.040 |
Why?
|
| Neck Muscles | 1 | 1999 | 100 | 0.040 |
Why?
|
| Infant, Newborn | 7 | 2020 | 26387 | 0.040 |
Why?
|
| Point Mutation | 1 | 2003 | 1592 | 0.040 |
Why?
|
| Immediate-Early Proteins | 1 | 2001 | 444 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 1998 | 149 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2012 | 1073 | 0.040 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2000 | 306 | 0.040 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2024 | 975 | 0.040 |
Why?
|
| Antigens, Differentiation | 2 | 1999 | 921 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 1999 | 610 | 0.040 |
Why?
|
| Respiratory Muscles | 1 | 1999 | 144 | 0.040 |
Why?
|
| STAT5 Transcription Factor | 1 | 2019 | 269 | 0.040 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2018 | 88 | 0.040 |
Why?
|
| Antibodies, Neoplasm | 1 | 1999 | 282 | 0.040 |
Why?
|
| Heart Atria | 1 | 2004 | 1362 | 0.040 |
Why?
|
| Leukemia | 1 | 2006 | 1521 | 0.040 |
Why?
|
| Reactive Oxygen Species | 3 | 2013 | 2144 | 0.040 |
Why?
|
| Laryngeal Muscles | 1 | 1999 | 107 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2020 | 630 | 0.040 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2001 | 327 | 0.040 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 1998 | 88 | 0.040 |
Why?
|
| In Situ Hybridization | 4 | 2006 | 1892 | 0.040 |
Why?
|
| Cholesterol | 3 | 2003 | 2904 | 0.040 |
Why?
|
| DNA Modification Methylases | 1 | 2018 | 207 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2020 | 828 | 0.040 |
Why?
|
| Binding Sites | 2 | 2006 | 6013 | 0.040 |
Why?
|
| Hydrocortisone | 2 | 2004 | 1838 | 0.040 |
Why?
|
| Cyclic GMP | 2 | 2009 | 394 | 0.040 |
Why?
|
| Inflammation | 3 | 2023 | 10863 | 0.040 |
Why?
|
| Butyrates | 2 | 1990 | 164 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 1998 | 521 | 0.040 |
Why?
|
| Germinal Center | 1 | 2020 | 379 | 0.040 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2017 | 96 | 0.040 |
Why?
|
| Retinoblastoma Protein | 1 | 2000 | 670 | 0.030 |
Why?
|
| Antiviral Agents | 3 | 2007 | 3070 | 0.030 |
Why?
|
| Hernia, Inguinal | 1 | 2000 | 224 | 0.030 |
Why?
|
| Transgenes | 2 | 2013 | 1014 | 0.030 |
Why?
|
| Immunoblotting | 2 | 2016 | 1647 | 0.030 |
Why?
|
| Antibodies, Blocking | 1 | 2017 | 250 | 0.030 |
Why?
|
| Trans-Activators | 3 | 2011 | 2856 | 0.030 |
Why?
|
| Movement Disorders | 1 | 2001 | 462 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1999 | 434 | 0.030 |
Why?
|
| Amino Acid Sequence | 4 | 2015 | 13411 | 0.030 |
Why?
|
| Anesthetics, Inhalation | 1 | 2002 | 573 | 0.030 |
Why?
|
| Shoulder | 1 | 1999 | 300 | 0.030 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1997 | 222 | 0.030 |
Why?
|
| Burkitt Lymphoma | 1 | 1999 | 338 | 0.030 |
Why?
|
| Metabolism | 1 | 1998 | 193 | 0.030 |
Why?
|
| Transfection | 2 | 2003 | 5755 | 0.030 |
Why?
|
| Colonic Neoplasms | 3 | 2001 | 2535 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2017 | 151 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1999 | 1622 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2020 | 812 | 0.030 |
Why?
|
| Fibrosarcoma | 1 | 1998 | 313 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2021 | 1742 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 3 | 2013 | 2730 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2007 | 5330 | 0.030 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1996 | 325 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2001 | 769 | 0.030 |
Why?
|
| Gaucher Disease | 1 | 1996 | 110 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2018 | 699 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2016 | 364 | 0.030 |
Why?
|
| Histones | 2 | 2024 | 2595 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2003 | 1621 | 0.030 |
Why?
|
| Gangliosides | 1 | 2016 | 132 | 0.030 |
Why?
|
| Hydroxamic Acids | 1 | 1998 | 483 | 0.030 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1995 | 73 | 0.030 |
Why?
|
| Sesquiterpenes | 1 | 1996 | 175 | 0.030 |
Why?
|
| Cathepsins | 1 | 2016 | 243 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6548 | 0.030 |
Why?
|
| Arm | 1 | 1999 | 591 | 0.030 |
Why?
|
| Glomerular Mesangium | 1 | 1995 | 98 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2015 | 3073 | 0.030 |
Why?
|
| Rosette Formation | 2 | 1986 | 152 | 0.030 |
Why?
|
| Retina | 1 | 1986 | 2660 | 0.030 |
Why?
|
| Sural Nerve | 2 | 2006 | 105 | 0.030 |
Why?
|
| Herpesviridae Infections | 1 | 1996 | 268 | 0.030 |
Why?
|
| Electron Transport Complex II | 1 | 2015 | 53 | 0.030 |
Why?
|
| Proteinuria | 1 | 2018 | 613 | 0.030 |
Why?
|
| Spleen | 2 | 2019 | 2295 | 0.030 |
Why?
|
| Glycolysis | 1 | 2019 | 837 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 1998 | 689 | 0.030 |
Why?
|
| Suramin | 1 | 1994 | 34 | 0.030 |
Why?
|
| Escherichia coli | 3 | 2013 | 4211 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 392 | 0.030 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2019 | 616 | 0.030 |
Why?
|
| Salivary Glands | 1 | 1996 | 231 | 0.030 |
Why?
|
| Thoracic Neoplasms | 2 | 1987 | 269 | 0.030 |
Why?
|
| Vimentin | 2 | 1996 | 257 | 0.030 |
Why?
|
| Complement C3b | 1 | 2014 | 98 | 0.030 |
Why?
|
| Acute Disease | 2 | 2002 | 7240 | 0.030 |
Why?
|
| Acidosis, Lactic | 1 | 1995 | 144 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2016 | 3605 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2007 | 6853 | 0.030 |
Why?
|
| Neurons | 7 | 2001 | 9515 | 0.030 |
Why?
|
| Endopeptidases | 2 | 2000 | 762 | 0.030 |
Why?
|
| Complement C4b | 1 | 2014 | 125 | 0.030 |
Why?
|
| Blood Flow Velocity | 2 | 2008 | 1374 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2003 | 2057 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2006 | 3440 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 1994 | 212 | 0.030 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1993 | 74 | 0.030 |
Why?
|
| Leg | 1 | 1999 | 1087 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2008 | 418 | 0.030 |
Why?
|
| RNA Interference | 2 | 2012 | 2829 | 0.030 |
Why?
|
| DNA, Viral | 5 | 2002 | 2201 | 0.030 |
Why?
|
| Berlin | 1 | 2013 | 23 | 0.030 |
Why?
|
| Antigens, CD | 3 | 2001 | 4033 | 0.030 |
Why?
|
| Drugs, Investigational | 1 | 1995 | 211 | 0.030 |
Why?
|
| Hepatitis B | 2 | 1997 | 710 | 0.030 |
Why?
|
| Liver Failure | 1 | 1995 | 253 | 0.030 |
Why?
|
| Neurosecretory Systems | 2 | 1993 | 223 | 0.030 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1995 | 154 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 2000 | 1110 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2013 | 36570 | 0.030 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2013 | 220 | 0.030 |
Why?
|
| Epithelial Cells | 3 | 2021 | 3698 | 0.030 |
Why?
|
| Vasodilation | 2 | 2007 | 968 | 0.030 |
Why?
|
| Syndrome | 3 | 2008 | 3271 | 0.030 |
Why?
|
| Niemann-Pick Diseases | 1 | 1992 | 27 | 0.030 |
Why?
|
| Biopsy | 3 | 2001 | 6779 | 0.030 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 1992 | 16 | 0.030 |
Why?
|
| Ganglioneuroma | 1 | 1993 | 53 | 0.030 |
Why?
|
| Mesenchymoma | 1 | 1993 | 50 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 3723 | 0.030 |
Why?
|
| Pepsin A | 1 | 1992 | 64 | 0.030 |
Why?
|
| Ligands | 1 | 1999 | 3274 | 0.030 |
Why?
|
| Histocytochemistry | 3 | 1994 | 697 | 0.030 |
Why?
|
| Hypertrophy | 2 | 2008 | 562 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 857 | 0.030 |
Why?
|
| Nitrites | 1 | 2012 | 156 | 0.030 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1994 | 271 | 0.030 |
Why?
|
| Recurrence | 3 | 2008 | 8507 | 0.020 |
Why?
|
| Iron | 1 | 2001 | 1812 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 2004 | 2043 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 18076 | 0.020 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2012 | 83 | 0.020 |
Why?
|
| Nephritis, Interstitial | 1 | 2013 | 157 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2006 | 939 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2008 | 2746 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 1995 | 741 | 0.020 |
Why?
|
| Ubiquinone | 1 | 2013 | 181 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2001 | 1885 | 0.020 |
Why?
|
| Cattle | 2 | 2008 | 3815 | 0.020 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2013 | 124 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 2 | 2007 | 316 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2001 | 1089 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2012 | 170 | 0.020 |
Why?
|
| Radiation, Ionizing | 1 | 2012 | 251 | 0.020 |
Why?
|
| Maryland | 1 | 2012 | 277 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2007 | 3421 | 0.020 |
Why?
|
| Pilot Projects | 4 | 2009 | 8728 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 1998 | 1170 | 0.020 |
Why?
|
| Kinetics | 1 | 1999 | 6288 | 0.020 |
Why?
|
| Chronic Disease | 3 | 2002 | 9358 | 0.020 |
Why?
|
| Phagosomes | 1 | 2012 | 194 | 0.020 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2011 | 23 | 0.020 |
Why?
|
| Microscopy, Confocal | 2 | 2013 | 1969 | 0.020 |
Why?
|
| Brain Diseases | 1 | 2000 | 1552 | 0.020 |
Why?
|
| Molecular Probes | 1 | 1993 | 309 | 0.020 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2011 | 35 | 0.020 |
Why?
|
| Cytochromes b | 1 | 2011 | 35 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2020 | 2328 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2012 | 474 | 0.020 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2011 | 52 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6214 | 0.020 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2011 | 70 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 4780 | 0.020 |
Why?
|
| Adipose Tissue | 2 | 2000 | 3317 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2012 | 10745 | 0.020 |
Why?
|
| Cytarabine | 1 | 1993 | 696 | 0.020 |
Why?
|
| Karyotyping | 2 | 2008 | 1176 | 0.020 |
Why?
|
| Ribonucleases | 1 | 1991 | 266 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2012 | 412 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2013 | 784 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2000 | 2815 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 2018 | 976 | 0.020 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 1991 | 94 | 0.020 |
Why?
|
| Butyric Acid | 2 | 1990 | 51 | 0.020 |
Why?
|
| Oncogenes | 2 | 1993 | 1232 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1998 | 1934 | 0.020 |
Why?
|
| Pyridines | 2 | 2012 | 2888 | 0.020 |
Why?
|
| Dimethylformamide | 1 | 1990 | 20 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2011 | 173 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2012 | 517 | 0.020 |
Why?
|
| Paraproteinemias | 1 | 2013 | 251 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2011 | 417 | 0.020 |
Why?
|
| Omentum | 1 | 1991 | 168 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2013 | 20710 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2000 | 2694 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1991 | 1305 | 0.020 |
Why?
|
| Osteolysis | 1 | 1991 | 273 | 0.020 |
Why?
|
| Superoxides | 1 | 2011 | 388 | 0.020 |
Why?
|
| Lipidoses | 1 | 1989 | 11 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 1110 | 0.020 |
Why?
|
| Carcinoid Tumor | 1 | 1991 | 225 | 0.020 |
Why?
|
| Proteins | 2 | 2002 | 6002 | 0.020 |
Why?
|
| Candida albicans | 1 | 2012 | 377 | 0.020 |
Why?
|
| Disease Progression | 3 | 2020 | 13642 | 0.020 |
Why?
|
| Antigens, Surface | 2 | 1992 | 1617 | 0.020 |
Why?
|
| Xanthomatosis | 1 | 1989 | 32 | 0.020 |
Why?
|
| Carbon-Carbon Ligases | 1 | 2008 | 19 | 0.020 |
Why?
|
| Liver Transplantation | 2 | 2018 | 2416 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2005 | 81657 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2011 | 403 | 0.020 |
Why?
|
| Energy Metabolism | 2 | 2011 | 2903 | 0.020 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2009 | 44 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2012 | 533 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 949 | 0.020 |
Why?
|
| Metanephrine | 1 | 2008 | 25 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2001 | 412 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2013 | 716 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1992 | 792 | 0.020 |
Why?
|
| Tongue Diseases | 1 | 1989 | 70 | 0.020 |
Why?
|
| Pedigree | 2 | 2008 | 4539 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2012 | 4853 | 0.020 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2008 | 105 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1993 | 903 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2012 | 562 | 0.020 |
Why?
|
| Immunity, Humoral | 1 | 2012 | 609 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2011 | 369 | 0.020 |
Why?
|
| Preventive Health Services | 1 | 2013 | 570 | 0.020 |
Why?
|
| Genes, Reporter | 2 | 2007 | 1525 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2012 | 715 | 0.020 |
Why?
|
| 2',3'-Cyclic-Nucleotide Phosphodiesterases | 1 | 1987 | 6 | 0.020 |
Why?
|
| Defective Viruses | 1 | 2008 | 89 | 0.020 |
Why?
|
| Cell Size | 2 | 2000 | 625 | 0.020 |
Why?
|
| Thrombospondins | 1 | 2008 | 196 | 0.020 |
Why?
|
| Homeostasis | 1 | 2019 | 3343 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 1057 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2013 | 2127 | 0.020 |
Why?
|
| HLA-DR Antigens | 2 | 2006 | 609 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 1646 | 0.020 |
Why?
|
| Catecholamines | 1 | 2008 | 388 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2008 | 265 | 0.020 |
Why?
|
| X-Rays | 1 | 2008 | 309 | 0.020 |
Why?
|
| Blood Component Removal | 1 | 2008 | 124 | 0.020 |
Why?
|
| Starvation | 1 | 2008 | 141 | 0.020 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2008 | 236 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 1992 | 771 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2015 | 3948 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2008 | 367 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1995 | 1374 | 0.020 |
Why?
|
| gp100 Melanoma Antigen | 1 | 2007 | 37 | 0.020 |
Why?
|
| Melanosomes | 1 | 2007 | 34 | 0.020 |
Why?
|
| Adenocarcinoma | 2 | 1995 | 6359 | 0.020 |
Why?
|
| Epigenomics | 1 | 2013 | 958 | 0.020 |
Why?
|
| Choline O-Acetyltransferase | 1 | 1987 | 156 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1999 | 3408 | 0.020 |
Why?
|
| Tritium | 1 | 2007 | 707 | 0.020 |
Why?
|
| Escherichia coli K12 | 1 | 2006 | 35 | 0.020 |
Why?
|
| Thymidine Kinase | 1 | 2007 | 286 | 0.020 |
Why?
|
| Cell Death | 2 | 2006 | 1676 | 0.020 |
Why?
|
| Aniline Compounds | 1 | 2012 | 1079 | 0.020 |
Why?
|
| Adrenalectomy | 2 | 2004 | 347 | 0.020 |
Why?
|
| Ligation | 1 | 2007 | 446 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2008 | 315 | 0.020 |
Why?
|
| Ganciclovir | 1 | 2007 | 256 | 0.020 |
Why?
|
| Schwann Cells | 1 | 1987 | 195 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2006 | 121 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1996 | 1433 | 0.020 |
Why?
|
| Sirtuin 1 | 1 | 2008 | 247 | 0.020 |
Why?
|
| Immunochemistry | 1 | 1986 | 116 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2011 | 701 | 0.020 |
Why?
|
| Cell Cycle | 2 | 2008 | 2925 | 0.020 |
Why?
|
| Vaccines, DNA | 1 | 2008 | 279 | 0.020 |
Why?
|
| Human Growth Hormone | 2 | 2004 | 640 | 0.020 |
Why?
|
| Blood Coagulation Factors | 1 | 2008 | 371 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2012 | 938 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2009 | 502 | 0.020 |
Why?
|
| Collateral Circulation | 1 | 2007 | 289 | 0.020 |
Why?
|
| Hemangioblastoma | 1 | 2006 | 62 | 0.020 |
Why?
|
| Extracellular Space | 2 | 2000 | 563 | 0.020 |
Why?
|
| Cardiac Myosins | 1 | 2006 | 128 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2001 | 826 | 0.020 |
Why?
|
| World Health Organization | 1 | 1992 | 1327 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2011 | 1716 | 0.020 |
Why?
|
| Laminin | 1 | 1987 | 404 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 1992 | 2350 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 1505 | 0.020 |
Why?
|
| Microvilli | 1 | 1986 | 234 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 1994 | 1938 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 6575 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 2215 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 1791 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2007 | 573 | 0.020 |
Why?
|
| Pyrimidines | 1 | 1998 | 3043 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2006 | 244 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2007 | 540 | 0.020 |
Why?
|
| Actins | 2 | 2006 | 2061 | 0.020 |
Why?
|
| Rats | 4 | 2007 | 23717 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2017 | 3079 | 0.020 |
Why?
|
| Acetylation | 1 | 2008 | 1055 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 2005 | 261 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1987 | 1729 | 0.020 |
Why?
|
| Cells | 1 | 1986 | 162 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2007 | 558 | 0.020 |
Why?
|
| Gene Frequency | 1 | 1992 | 3624 | 0.010 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2006 | 304 | 0.010 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 5795 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3828 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 2 | 2006 | 2631 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 11514 | 0.010 |
Why?
|
| Pregnancy | 1 | 2006 | 30236 | 0.010 |
Why?
|
| Genotype | 2 | 2013 | 13036 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2007 | 898 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2013 | 2232 | 0.010 |
Why?
|
| Cytological Techniques | 1 | 1986 | 217 | 0.010 |
Why?
|
| NFATC Transcription Factors | 1 | 2006 | 393 | 0.010 |
Why?
|
| Peritoneal Neoplasms | 1 | 1991 | 706 | 0.010 |
Why?
|
| DNA Mutational Analysis | 2 | 2008 | 4114 | 0.010 |
Why?
|
| Indoles | 1 | 2012 | 1834 | 0.010 |
Why?
|
| Herpesvirus 6, Human | 1 | 2004 | 96 | 0.010 |
Why?
|
| Mitochondrial Diseases | 1 | 2008 | 344 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2007 | 1478 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2000 | 8108 | 0.010 |
Why?
|
| Melanocytes | 1 | 1987 | 509 | 0.010 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1993 | 1561 | 0.010 |
Why?
|
| Fibronectins | 1 | 1987 | 722 | 0.010 |
Why?
|
| Fluorescence | 1 | 1986 | 751 | 0.010 |
Why?
|
| Zebrafish | 1 | 2015 | 3035 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2006 | 911 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2006 | 696 | 0.010 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1995 | 1642 | 0.010 |
Why?
|
| Immunoglobulins | 2 | 1999 | 853 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 2045 | 0.010 |
Why?
|
| Sterols | 1 | 2003 | 63 | 0.010 |
Why?
|
| Tyrphostins | 1 | 2003 | 62 | 0.010 |
Why?
|
| Cytosol | 1 | 2006 | 887 | 0.010 |
Why?
|
| Femoral Artery | 1 | 2007 | 827 | 0.010 |
Why?
|
| Cricetinae | 1 | 2007 | 2416 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 1998 | 618 | 0.010 |
Why?
|
| DNA | 3 | 2005 | 7210 | 0.010 |
Why?
|
| Splenomegaly | 1 | 1983 | 191 | 0.010 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2003 | 42 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 1996 | 3306 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1992 | 6329 | 0.010 |
Why?
|
| Blood Vessels | 1 | 2008 | 1111 | 0.010 |
Why?
|
| Myoglobin | 1 | 1983 | 158 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2008 | 1206 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2006 | 627 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2005 | 640 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2007 | 2275 | 0.010 |
Why?
|
| Filipin | 1 | 2002 | 14 | 0.010 |
Why?
|
| Dehydrocholesterols | 1 | 2002 | 20 | 0.010 |
Why?
|
| Particle Size | 1 | 2007 | 1633 | 0.010 |
Why?
|
| Immune Sera | 1 | 1983 | 605 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2003 | 455 | 0.010 |
Why?
|
| JC Virus | 1 | 2002 | 87 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 2003 | 287 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2007 | 1392 | 0.010 |
Why?
|
| Ifosfamide | 2 | 1996 | 233 | 0.010 |
Why?
|
| Extremities | 1 | 1987 | 869 | 0.010 |
Why?
|
| Chromogranins | 2 | 1994 | 160 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2003 | 254 | 0.010 |
Why?
|
| Heterozygote | 1 | 2008 | 2795 | 0.010 |
Why?
|
| Cell Count | 2 | 1996 | 1826 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2007 | 1459 | 0.010 |
Why?
|
| Cell Adhesion | 2 | 2000 | 3093 | 0.010 |
Why?
|
| Cerebellar Neoplasms | 1 | 2006 | 588 | 0.010 |
Why?
|
| Herpesvirus 1, Human | 1 | 2007 | 743 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2006 | 1103 | 0.010 |
Why?
|
| Myosins | 1 | 1983 | 407 | 0.010 |
Why?
|
| Cholinergic Agonists | 1 | 2001 | 75 | 0.010 |
Why?
|
| Body Composition | 1 | 2011 | 2441 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2006 | 1331 | 0.010 |
Why?
|
| Transaminases | 1 | 2002 | 198 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2003 | 607 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 526 | 0.010 |
Why?
|
| Iron Regulatory Protein 2 | 1 | 2001 | 43 | 0.010 |
Why?
|
| Iron-Regulatory Proteins | 1 | 2001 | 30 | 0.010 |
Why?
|
| Protein Transport | 1 | 2007 | 1944 | 0.010 |
Why?
|
| Etoposide | 2 | 1996 | 638 | 0.010 |
Why?
|
| Iron Regulatory Protein 1 | 1 | 2001 | 40 | 0.010 |
Why?
|
| Carbachol | 1 | 2001 | 223 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1983 | 684 | 0.010 |
Why?
|
| Receptors, Muscarinic | 1 | 2001 | 156 | 0.010 |
Why?
|
| Genes, Retinoblastoma | 1 | 2001 | 125 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2001 | 228 | 0.010 |
Why?
|
| Acromegaly | 1 | 2004 | 316 | 0.010 |
Why?
|
| Mitotic Index | 1 | 2000 | 160 | 0.010 |
Why?
|
| Down-Regulation | 2 | 2000 | 2931 | 0.010 |
Why?
|
| Genes, cdc | 1 | 2000 | 113 | 0.010 |
Why?
|
| Retroviridae Proteins | 1 | 2000 | 94 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2006 | 1144 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2006 | 1560 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 2002 | 527 | 0.010 |
Why?
|
| Hormones | 1 | 2004 | 866 | 0.010 |
Why?
|
| Neuroglia | 1 | 1986 | 960 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 2221 | 0.010 |
Why?
|
| Trigeminal Ganglion | 1 | 2001 | 186 | 0.010 |
Why?
|
| Lethal Dose 50 | 1 | 2000 | 71 | 0.010 |
Why?
|
| Vincristine | 2 | 1996 | 1040 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2001 | 348 | 0.010 |
Why?
|
| Sheep | 1 | 1983 | 1448 | 0.010 |
Why?
|
| Carrageenan | 1 | 2000 | 71 | 0.010 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1244 | 0.010 |
Why?
|
| Aspergillus fumigatus | 1 | 2001 | 158 | 0.010 |
Why?
|
| Chemotaxis | 1 | 2003 | 598 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2000 | 317 | 0.010 |
Why?
|
| Putamen | 1 | 2001 | 288 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1995 | 2470 | 0.010 |
Why?
|
| Patient Selection | 1 | 2012 | 4252 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2001 | 645 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2011 | 3139 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2000 | 634 | 0.010 |
Why?
|
| Myelin Sheath | 1 | 2003 | 650 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2000 | 376 | 0.010 |
Why?
|
| Ciprofloxacin | 1 | 2001 | 314 | 0.010 |
Why?
|
| Endostatins | 1 | 2000 | 167 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1986 | 1478 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2009 | 2926 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2008 | 1893 | 0.010 |
Why?
|
| Ubiquitins | 1 | 2001 | 365 | 0.010 |
Why?
|
| Remission Induction | 1 | 2005 | 2413 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2008 | 1594 | 0.010 |
Why?
|
| Purkinje Cells | 1 | 2001 | 228 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2013 | 5344 | 0.010 |
Why?
|
| Antigens | 1 | 1984 | 1442 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1992 | 12064 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 1999 | 364 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2000 | 252 | 0.010 |
Why?
|
| Pharmaceutical Preparations | 1 | 2007 | 1086 | 0.010 |
Why?
|
| Receptors, Leptin | 1 | 2000 | 352 | 0.010 |
Why?
|
| Homozygote | 1 | 2003 | 1775 | 0.010 |
Why?
|
| Cyclins | 1 | 2000 | 605 | 0.010 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 1998 | 35 | 0.010 |
Why?
|
| Echocardiography | 1 | 2011 | 5038 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2005 | 2244 | 0.010 |
Why?
|
| Viral Matrix Proteins | 1 | 1999 | 193 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2008 | 2978 | 0.010 |
Why?
|
| Ferritins | 1 | 2001 | 601 | 0.010 |
Why?
|
| Gastric Acid | 1 | 1998 | 98 | 0.010 |
Why?
|
| Duodenum | 1 | 2001 | 495 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2000 | 656 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2002 | 1494 | 0.010 |
Why?
|
| Corticosterone | 1 | 1998 | 301 | 0.010 |
Why?
|
| Virus Activation | 1 | 1999 | 322 | 0.010 |
Why?
|
| Graft Survival | 1 | 2008 | 3904 | 0.010 |
Why?
|
| Oligodendroglia | 1 | 2001 | 539 | 0.010 |
Why?
|
| Saphenous Vein | 1 | 2000 | 519 | 0.010 |
Why?
|
| Cyclophosphamide | 2 | 1996 | 2234 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2005 | 1672 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1998 | 1082 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 4618 | 0.010 |
Why?
|
| Endarterectomy, Carotid | 1 | 2002 | 556 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2005 | 3552 | 0.010 |
Why?
|
| Cyclohexanes | 1 | 1996 | 151 | 0.010 |
Why?
|
| Diethylamines | 1 | 1995 | 3 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1996 | 226 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2001 | 1615 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIIbeta Subunit | 1 | 1995 | 6 | 0.010 |
Why?
|
| Receptors, Interferon | 1 | 1996 | 115 | 0.010 |
Why?
|
| DNA Damage | 2 | 1996 | 2469 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2000 | 1606 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 1995 | 24 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 3511 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2000 | 2478 | 0.010 |
Why?
|
| Species Specificity | 1 | 2000 | 2413 | 0.010 |
Why?
|
| Thymidine | 1 | 1995 | 297 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 1993 | 1442 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 15425 | 0.010 |
Why?
|
| Siderophores | 1 | 1995 | 61 | 0.010 |
Why?
|
| Catalase | 1 | 1995 | 215 | 0.010 |
Why?
|
| Deferoxamine | 1 | 1995 | 155 | 0.010 |
Why?
|
| Jaundice | 1 | 1995 | 95 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2003 | 1965 | 0.010 |
Why?
|
| Rabbits | 1 | 2001 | 4752 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 2000 | 703 | 0.010 |
Why?
|
| Oxygen | 1 | 2006 | 4252 | 0.010 |
Why?
|
| Virus Replication | 1 | 2002 | 2457 | 0.010 |
Why?
|
| HIV Seropositivity | 1 | 2000 | 962 | 0.010 |
Why?
|
| Chromogranin A | 1 | 1994 | 47 | 0.010 |
Why?
|
| Thalamus | 1 | 2001 | 1040 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2000 | 1334 | 0.010 |
Why?
|
| Classification | 1 | 1994 | 128 | 0.010 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 1997 | 638 | 0.010 |
Why?
|
| Drug Resistance, Multiple | 1 | 1995 | 256 | 0.010 |
Why?
|
| Endocrine Glands | 1 | 1994 | 101 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2001 | 1497 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2002 | 4860 | 0.010 |
Why?
|
| Vinblastine | 1 | 1995 | 482 | 0.010 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1993 | 93 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2001 | 1276 | 0.010 |
Why?
|
| Stem Cells | 1 | 2006 | 3536 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2882 | 0.010 |
Why?
|
| Sarcoma, Kaposi | 1 | 1996 | 376 | 0.010 |
Why?
|
| Cerebellum | 1 | 2001 | 1520 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 3759 | 0.010 |
Why?
|
| Insulin | 1 | 2008 | 6608 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2001 | 2669 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 3446 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 1995 | 661 | 0.010 |
Why?
|
| Glutathione | 1 | 1995 | 589 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 1995 | 596 | 0.010 |
Why?
|
| Follow-Up Studies | 4 | 2004 | 39312 | 0.010 |
Why?
|
| Culture Media | 1 | 1995 | 893 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 1995 | 608 | 0.010 |
Why?
|
| Brain | 3 | 2013 | 27158 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2000 | 1368 | 0.010 |
Why?
|
| Nifedipine | 1 | 1993 | 220 | 0.010 |
Why?
|
| Verapamil | 1 | 1993 | 242 | 0.010 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 1993 | 117 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2000 | 1962 | 0.010 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 1994 | 718 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1992 | 147 | 0.010 |
Why?
|
| Algorithms | 1 | 2012 | 14073 | 0.010 |
Why?
|
| Radiotherapy Dosage | 2 | 1989 | 2916 | 0.010 |
Why?
|
| Bombesin | 1 | 1991 | 35 | 0.010 |
Why?
|
| Pathology | 1 | 1994 | 270 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1994 | 11094 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1995 | 1757 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1995 | 1750 | 0.010 |
Why?
|
| Synaptophysin | 1 | 1991 | 138 | 0.010 |
Why?
|
| Neutropenia | 1 | 1996 | 895 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1995 | 1477 | 0.010 |
Why?
|
| Codon | 1 | 1992 | 599 | 0.010 |
Why?
|
| Monocytes | 1 | 2000 | 2599 | 0.010 |
Why?
|
| Adrenocortical Hyperfunction | 1 | 1989 | 13 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1991 | 338 | 0.010 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1990 | 134 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2001 | 3041 | 0.010 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1995 | 713 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 1993 | 572 | 0.010 |
Why?
|
| Pneumonia | 1 | 2001 | 2161 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1990 | 861 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 7612 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1987 | 9407 | 0.000 |
Why?
|
| Cell Movement | 1 | 2000 | 5204 | 0.000 |
Why?
|
| Pancreatitis | 1 | 1995 | 1087 | 0.000 |
Why?
|
| Immunophenotyping | 1 | 1993 | 1867 | 0.000 |
Why?
|
| Palatine Tonsil | 1 | 1989 | 193 | 0.000 |
Why?
|
| Thrombocytopenia | 1 | 1996 | 1172 | 0.000 |
Why?
|
| Protein Binding | 1 | 2000 | 9326 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1995 | 21162 | 0.000 |
Why?
|
| Risk | 1 | 2000 | 9602 | 0.000 |
Why?
|
| Mesna | 1 | 1987 | 62 | 0.000 |
Why?
|
| Endothelium, Vascular | 1 | 2000 | 4424 | 0.000 |
Why?
|
| Pulmonary Embolism | 1 | 2001 | 2596 | 0.000 |
Why?
|
| Dactinomycin | 1 | 1987 | 304 | 0.000 |
Why?
|
| Cystitis | 1 | 1987 | 96 | 0.000 |
Why?
|
| Alkaline Phosphatase | 1 | 1990 | 855 | 0.000 |
Why?
|
| Periodic Acid-Schiff Reaction | 1 | 1986 | 16 | 0.000 |
Why?
|
| Vascular Diseases | 1 | 1994 | 1161 | 0.000 |
Why?
|
| Exons | 1 | 1992 | 2392 | 0.000 |
Why?
|
| Intercostal Nerves | 1 | 1986 | 29 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1987 | 642 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2008 | 41706 | 0.000 |
Why?
|
| Bone Marrow Diseases | 1 | 1987 | 234 | 0.000 |
Why?
|
| United States | 1 | 1992 | 72945 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1995 | 5795 | 0.000 |
Why?
|
| Age Factors | 1 | 2001 | 18397 | 0.000 |
Why?
|
| Terminology as Topic | 1 | 1991 | 1540 | 0.000 |
Why?
|
| Cytoplasmic Granules | 1 | 1986 | 574 | 0.000 |
Why?
|
| Papillomaviridae | 1 | 1989 | 1139 | 0.000 |
Why?
|
| Plasma Cells | 1 | 1984 | 599 | 0.000 |
Why?
|
| Cerebral Angiography | 1 | 1986 | 1263 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1996 | 4356 | 0.000 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1989 | 1884 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2002 | 15831 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1997 | 10384 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1994 | 20146 | 0.000 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 1991 | 5389 | 0.000 |
Why?
|
| Heart Failure | 1 | 1996 | 11879 | 0.000 |
Why?
|